 |
|
|
| |
Routinely Available Noninvasive Tests Perform Well in Identifying Patients with
Advanced Fibrosis Due to NASH: Data from the TARGET-NASH Observational Cohort
|
| |
| |
AASLD 2019 Nov 8-12 Boston
Reported by Jules Levin
AS Barritt IV,1 AS Lok2, KR Reddy3, LM Weiss4, RJ Firpi5, PJ Thuluvath6, HN Trinh7, S Djedjos8, R Haubrich8, A Billin8, B Koch II8, R Zink9, AJ Sanyal10, K Cusi11, BA Neuschwander-Tetri12
1Gastroenterology and Hepatology, University of North Carolina at Chapel Hill, Chapel Hill, NC; 2Division of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, MI; 3University of Pennsylvania, Philadelphia, PA; 4Gastro Florida, Clearwater, FL; 5Division of Gastroenterology, Hepatology and Nutrition, University of Florida, Gainesville, FL; 6Medicine, Mercy Medical Center & University of Maryland School of Medicine, Baltimore, MD; 7San Jose Gastroenterology, San Jose, CA; 8Gilead Sciences, Inc., Foster City, CA; 9TARGET PharmaSolutions, Inc., Durham, NC; 10Virginia Commonwealth University, Richmond, VA; 11Division of Endocrinology, Diabetes and Metabolism, University of Florida, Gainesville, Florida; 12Division of Gastroenterology and Hepatology, Saint Louis University School of Medicine, St. Louis, MO
|
| |
|
|
|
|
|
